Avance Biosciences Plays Key Role in RNA Sequencing for Promising COVID-19 Vaccine
Joshua Fu2025-04-02T21:48:36+00:00Avance Biosciences contributed critical RNA sequencing to the development of MV-014-212, a novel intranasal COVID-19 vaccine. In preclinical trials, MV-014-212 showed significant promise by reducing viral shedding and eliciting a broad immune response, including protection against multiple variants of concern...
